# Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus

> **NCT01715935** · PHASE2 · COMPLETED · sponsor: **Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie** · enrollment: 25 (actual)

## Conditions studied

- Clear-cell Renal Carcinoma
- Clear-cell Metastatic Renal Cell Carcinoma

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT01715935
- **Lead sponsor:** Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2015-06
- **Final completion:** 2016-04
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01715935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01715935, "Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01715935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*